CLX CLOROX CO /DE/


$ 109.51 $ -1.99 (-1.78 %)    

Tuesday, 04-Nov-2025 12:34:11 EST
QQQ $ 622.22 $ -1.03 (-0.17 %)
DIA $ 471.05 $ 0.69 (0.15 %)
SPY $ 676.66 $ 0.53 (0.08 %)
TLT $ 89.97 $ 0.17 (0.19 %)
GLD $ 364.75 $ 1.09 (0.3 %)
$ na
$ 111.85
$ 109.45 x 615
$ 109.54 x 92
$ 107.72 - $ 113.11
$ 108.93 - $ 165.17
3,413,065
na
13.31B
$ 0.47
$ 16.83
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-maintains-equal-weight-on-clorox-lowers-price-target-to-125

Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $137 ...

 wells-fargo-maintains-equal-weight-on-clorox-lowers-price-target-to-117

Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $125 to $117.

 jp-morgan-maintains-neutral-on-clorox-lowers-price-target-to-120

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $127 to $120.

 clorox-affirms-fy2026-adj-eps-guidance-of-595-630-vs-595-est

Clorox (NYSE:CLX) affirms FY2026 Adj EPS guidance from $5.95-$6.30 to $5.95-$6.30 vs $5.95 analyst estimate..

 clorox-q1-adj-eps-085-beats-079-estimate-sales-1429b-beat-1400b-estimate

Clorox (NYSE:CLX) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.79 by 8.01 per...

 nvidia-amazon-extend-rally-bitcoin-sinks-to-107000-whats-moving-markets-monday

Wall Street opened the week on a mixed note on Monday.

 how-to-earn-500-a-month-from-clorox-stock-ahead-of-q1-earnings

Clorox (CLX) to release Q1 earnings on Nov. 3, analysts expect 78 cents/share, down from $1.86 last year. Annual dividend yield...

 jp-morgan-maintains-neutral-on-clorox-lowers-price-target-to-127

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $135 to $127.

 citigroup-maintains-neutral-on-clorox-lowers-price-target-to-130

Citigroup analyst Filippo Falorni maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $135 to $130.

 b-of-a-securities-maintains-neutral-on-clorox-lowers-price-target-to-125

B of A Securities analyst Anna Lizzul maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $135 to $125.

 ubs-maintains-neutral-on-clorox-lowers-price-target-to-128

UBS analyst Peter Grom maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $134 to $128.

 barclays-maintains-underweight-on-clorox-lowers-price-target-to-112

Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $118 to $112.

 the-analyst-verdict-clorox-in-the-eyes-of-10-experts

Analysts' ratings for Clorox (NYSE: CLX) over the last quarter vary from bullish to bearish, as provided by 10 analysts. Th...

 wells-fargo-maintains-equal-weight-on-clorox-lowers-price-target-to-125

Wells Fargo analyst Chris Carey maintains Clorox (NYSE: CLX) with a Equal-Weight and lowers the price target from $130 to $1...

 jp-morgan-maintains-neutral-on-clorox-raises-price-target-to-135

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and raises the price target from $133 to $135.

 where-clorox-stands-with-analysts
Where Clorox Stands With Analysts
09/05/2025 21:00:59

 wells-fargo-maintains-equal-weight-on-clorox-lowers-price-target-to-130

Wells Fargo analyst Chris Carey maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $138 to $130.

 morgan-stanley-maintains-equal-weight-on-clorox-lowers-price-target-to-137

Morgan Stanley analyst Dara Mohsenian maintains Clorox (NYSE:CLX) with a Equal-Weight and lowers the price target from $150 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION